The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn’s disease: Relations to disease activity and corticosteroid treatment

Growth Hormone & IGF Research - Tập 17 - Trang 33-40 - 2007
Martin Eivindson1, Henning Grønbæk1, Allan Flyvbjerg2, Jan Frystyk2, Erik Zimmermann-Nielsen3, Jens Frederik Dahlerup1
1Department of Gastroenterology and Hepatology, Aarhus University Hospital, VLN-Research, Nørrebrogade 44, Building 1c, 2. floor, DK-8000 Aarhus C, Denmark
2Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
3Surgical Department K, Hospital of Funen, Svendborg, Denmark

Tài liệu tham khảo

Jahnsen, 1997, Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study, Gut, 40, 313, 10.1136/gut.40.3.313

Vestergaard, 2000, Fracture risk is increased in Crohn’s disease, but not in ulcerative colitis, Gut, 46, 176, 10.1136/gut.46.2.176

Le Roith, 2001, The somatomedin hypothesis: 2001, Endocr. Rev., 22, 53, 10.1210/edrv.22.1.0419

Le Roith, 2001, What is the role of circulating IGF-I?, Trends Endocrinol. Metab., 12, 48, 10.1016/S1043-2760(00)00349-0

Bach, 1995, Insulin-like growth factor binding proteins, Diabetes Rev., 3, 38

Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3

Bereket, 1995, Insulin-like growth factor-binding protein-2 and insulin: studies in children with type 1 diabetes mellitus and maturity-onset diabetes of the young, J. Clin. Endocrinol. Metab., 80, 3647, 10.1210/jcem.80.12.8530614

Cohen, 1993, Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients, J. Clin. Endocrinol. Metab., 76, 1031

Helle, 2001, The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy, J. Clin. Endocrinol. Metab., 86, 227

Kratzsch, 1995, Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding protein-1, -2, -3 and GH binding protein during progression of liver cirrhosis, Exp. Clin. Endocrinol. Diabetes, 103, 285, 10.1055/s-0029-1211366

Allen, 1998, Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis, Am. J. Respir. Cell Mol. Biol., 19, 250, 10.1165/ajrcmb.19.2.3080

Corkins, 2003, The insulin-like growth factor axis in children with inflammatory bowel disease, J. Pediatr. Gastroenterol. Nutr., 36, 228, 10.1097/00005176-200302000-00014

Miell, 1993, The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers, J. Endocrinol., 136, 525, 10.1677/joe.0.1360525

Ballinger, 2001, Growth failure and intestinal inflammation, QJM, 94, 121, 10.1093/qjmed/94.3.121

Bannerjee, 2004, Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease, J. Pediatr. Gastroenterol. Nutr., 38, 270, 10.1097/00005176-200403000-00007

Juul, 2003, Serum levels of insulin-like growth factor I and its binding proteins in health and disease, Growth Horm. IGF. Res., 13, 113, 10.1016/S1096-6374(03)00038-8

Grønbæk, 2002, Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment, Am. J. Gastroenterol., 97, 673, 10.1016/S0002-9270(01)04110-7

Harvey, 1980, A simple index of Crohn’s-disease activity, Lancet, 1, 514, 10.1016/S0140-6736(80)92767-1

Frystyk, 1995, Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II, Growth Regul., 5, 169

Frystyk, 1994, Free insulin-like growth factors (IGF-I and IGF-II) in human serum, FEBS Lett., 348, 185, 10.1016/0014-5793(94)00602-4

Krassas, 2003, Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease, J. Clin. Endocrinol. Metab., 88, 132, 10.1210/jc.2002-021349

Westwood, 1994, The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy, J. Clin. Endocrinol. Metab., 79, 1735

Kirschner, 1986, Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease, Gastroenterology, 91, 830, 10.1016/0016-5085(86)90683-9

Tenore, 1977, Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease, J. Clin. Endocrinol. Metab., 44, 622, 10.1210/jcem-44-4-622

Thomas, 1993, Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn’s disease, Gut, 34, 944, 10.1136/gut.34.7.944

Eivindson, 2005, Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn’s disease treated with omega-3 or omega-6 fatty acids and corticosteroids, Scand. J. Gastroenterol., 40, 1214, 10.1080/00365520510015728

Katsanos, 2001, Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease, Growth Horm. IGF. Res., 11, 364, 10.1054/ghir.2001.0248

Hotta, 2000, The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa, J. Clin. Endocrinol. Metab., 85, 200

Thissen, 1994, Nutritional regulation of the insulin-like growth factors, Endocr. Rev., 15, 80

Underwood, 1996, Nutritional regulation of IGF-I and IGFBPs, J. Pediatr. Endocrinol. Metab., 9, 303

Unterman, 1985, Glucocorticoid effects on somatomedins and somatomedin inhibitors, J. Clin. Endocrinol. Metab., 61, 618, 10.1210/jcem-61-4-618

Støving, 2003, Low levels of the 150-kD insulin-like growth factor binding protein 3 ternary complex in patients with anorexia nervosa: effect of partial weight recovery, Horm. Res., 60, 43

Nørrelund, 2003, The effect of growth hormone on the insulin-like growth factor system during fasting, J. Clin. Endocrinol. Metab., 88, 3292, 10.1210/jc.2002-021983

Frystyk, 1996, Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty, Circulation, 94, 2465, 10.1161/01.CIR.94.10.2465

Frystyk, 1995, Free insulin-like growth factors in human obesity, Metabolism, 44, 37, 10.1016/0026-0495(95)90219-8

Jenkins, 1998, Acquired growth hormone resistance in adults, Baillieres Clin. Endocrinol. Metab., 12, 315, 10.1016/S0950-351X(98)80025-6

Ballinger, 2002, Fundamental mechanisms of growth failure in inflammatory bowel disease, Horm. Res., 58, 7

Wolf, 1996, Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells, Eur. J. Endocrinol., 135, 729, 10.1530/eje.0.1350729

Theiss, 2004, Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I, Inflamm. Bowel. Dis., 10, 871, 10.1097/00054725-200411000-00021

Mauras, 2002, Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study, Metabolism, 51, 127, 10.1053/meta.2002.28972

Hyams, 1991, Development and validation of a pediatric Crohn’s disease activity index, J. Pediatr. Gastroenterol. Nutr., 12, 439, 10.1097/00005176-199105000-00005

Slonim, 2000, A preliminary study of growth hormone therapy for Crohn’s disease, N. Engl. J. Med., 342, 1633, 10.1056/NEJM200006013422203

Thông tin
Thông tin xuất bản

Growth Hormone & IGF Research

Tập 17

33-40

Thông tin tác giả